Summit Therapeutics Inc.
SMMT
$18.22
-$0.69-3.65%
NASDAQ
| 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | |
|---|---|---|---|---|---|
| Net Income | 59.03% | -799.19% | -2.79% | -8.80% | 6.84% |
| Total Depreciation and Amortization | 13.51% | 48.00% | 13.64% | 10.00% | 0.00% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -72.61% | 5,939.99% | -40.08% | -22.24% | -30.37% |
| Change in Net Operating Assets | -63.27% | 446.02% | -801.75% | -107.65% | 199.30% |
| Cash from Operations | -39.46% | -9.12% | -25.67% | -60.65% | 8.20% |
| Capital Expenditure | -- | 100.00% | -2,914.29% | 75.86% | 7.94% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -100.00% | -6.06% | 92.26% | 176.91% | 45.73% |
| Cash from Investing | -100.05% | -5.81% | 91.79% | 176.86% | 45.71% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | 67.55% | -- |
| Issuance of Common Stock | 1,421.74% | -71.06% | 764.53% | -99.68% | 39.67% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 1,421.74% | -71.06% | 132.51% | -111.57% | 1.96% |
| Foreign Exchange rate Adjustments | -63.93% | 60.53% | 135.19% | -194.74% | 850.00% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -168.69% | -19.04% | 861.83% | -83.03% | 298.87% |